Paper17124530
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
Thera MA and 15 others. PLoS Clin Trials, 2006. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial. Papers, record 17124530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17124530
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| D43 TW001589 | FIC NIH HHS | United States | D43TW001589 | PubMed and NIH | NIH RePORTER |
| N01 AI085346 | NIAID NIH HHS | United States | N01AI085346 | PubMed and NIH | NIH RePORTER |
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12518850 | Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. | Am J Trop Med Hyg | 2002 | https://conductscience.org/library/papers/12518850 | PubMed |
| 2 | 1538134 | Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. | J Immunol | 1992 | https://conductscience.org/library/papers/1538134 | PubMed |
| 3 | 3079521 | Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. | J Mol Biol | 1987 | https://conductscience.org/library/papers/3079521 | PubMed |
| 4 | 12742586 | Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine. | Mol Biochem Parasitol | 2003 | https://conductscience.org/library/papers/12742586 | PubMed |
| 5 | 15618165 | The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. | Infect Immun | 2005 | https://conductscience.org/library/papers/15618165 | PubMed |
| 6 | 16338450 | Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. | Lancet | 2005 | https://conductscience.org/library/papers/16338450 | PubMed |
| 7 | 10697894 | Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. | Parassitologia | 1999 | https://conductscience.org/library/papers/10697894 | PubMed |
| 8 | 16356603 | Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. | Vaccine | 2006 | https://conductscience.org/library/papers/16356603 | PubMed |
| 9 | 15983925 | Community permission for medical research in developing countries. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15983925 | PubMed |
| 10 | 8577318 | Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. | Mol Biochem Parasitol | 1995 | https://conductscience.org/library/papers/8577318 | PubMed |
| 11 | 15463788 | The major merozoite surface protein as a malaria vaccine target. | Parasitol Today | 1993 | https://conductscience.org/library/papers/15463788 | PubMed |
| 12 | 15297070 | Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. | Vaccine | 2004 | https://conductscience.org/library/papers/15297070 | PubMed |
| 13 | 15755604 | Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. | Vaccine | 2005 | https://conductscience.org/library/papers/15755604 | PubMed |
| 14 | 16626494 | A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa. | Malar J | 2006 | https://conductscience.org/library/papers/16626494 | PubMed |
| 15 | 15488216 | Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. | Lancet | 2004 | https://conductscience.org/library/papers/15488216 | PubMed |
| 16 | 8368766 | Adjuvant activity of QS-21 isomers. | Ann N Y Acad Sci | 1993 | https://conductscience.org/library/papers/8368766 | PubMed |
| 17 | 16388879 | Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. | Vaccine | 2007 | https://conductscience.org/library/papers/16388879 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39025972 | Malaria vaccines: a new era of prevention and control. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/39025972 | PubMed |
| 33789984 | Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2-Based Antigen in a Trivalent, Multistage Malaria Vaccine. | J Immunol | 2021 | https://conductscience.org/library/papers/33789984 | PubMed |
| 32348377 | Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination. | PLoS One | 2020 | https://conductscience.org/library/papers/32348377 | PubMed |
| 32127565 | Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. | Sci Rep | 2020 | https://conductscience.org/library/papers/32127565 | PubMed |
| 30658710 | Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A. | Malar J | 2019 | https://conductscience.org/library/papers/30658710 | PubMed |
| 30621160 | Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities. | Molecules | 2019 | https://conductscience.org/library/papers/30621160 | PubMed |
| 29062081 | An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies. | Sci Rep | 2017 | https://conductscience.org/library/papers/29062081 | PubMed |
| 28993460 | Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate. | Infect Immun | 2018 | https://conductscience.org/library/papers/28993460 | PubMed |
| 27852258 | Allele-specific antibodies to Plasmodium vivax merozoite surface protein-1: prevalence and inverse relationship to haemoglobin levels during infection. | Malar J | 2016 | https://conductscience.org/library/papers/27852258 | PubMed |
| 26833236 | Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. | FEMS Microbiol Rev | 2016 | https://conductscience.org/library/papers/26833236 | PubMed |
| 26475447 | Designing malaria vaccines to circumvent antigen variability. | Vaccine | 2015 | https://conductscience.org/library/papers/26475447 | PubMed |
| 25918203 | Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women. | Am J Trop Med Hyg | 2015 | https://conductscience.org/library/papers/25918203 | PubMed |
| 25294612 | Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. | Am J Trop Med Hyg | 2015 | https://conductscience.org/library/papers/25294612 | PubMed |
| 25238721 | Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali. | Malar J | 2014 | https://conductscience.org/library/papers/25238721 | PubMed |
| 24354660 | Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-142 (MSP-142). | Malar J | 2013 | https://conductscience.org/library/papers/24354660 | PubMed |
| 23911334 | Transplacentally transferred functional antibodies against Plasmodium falciparum decrease with age. | Acta Trop | 2013 | https://conductscience.org/library/papers/23911334 | PubMed |
| 23897613 | A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies. | Infect Immun | 2013 | https://conductscience.org/library/papers/23897613 | PubMed |
| 23342996 | Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01. | Malar J | 2013 | https://conductscience.org/library/papers/23342996 | PubMed |
| 23146673 | A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. | Vaccine | 2013 | https://conductscience.org/library/papers/23146673 | PubMed |
| 22958482 | Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine. | Malar J | 2012 | https://conductscience.org/library/papers/22958482 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17124530
GET https://conductscience.org/api/papers/v1/17124530/cited_by?page=2